BIDMC Research At a Glance

The world-renowned research program at Beth Israel Deaconess Medical Center couples highly innovative scientific discoveries with a patient-centered mindset.

Investigations range from basic laboratory studies that are revealing fundamental, scientific advances to clinical and translational research that is leading to new therapies, diagnostics and changes that will significantly influence and impact human health.

  • BIDMC research is led by 250 Principal Investigators who are Harvard Medical School faculty.
  • Investigators at BIDMC lead more than 1,300 active sponsored projects.
  • BIDMC has more than 2,500 active exempt, expedited, and full board-reviewed clinical research studies.
  • Research funding averages $250 million, including government, corporate, foundation and internal donor sources.
  • BIDMC consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. Funding from the NIH and other federal sources averages more than $150 million. NIH grants represent a wide spectrum of influential and innovative research projects, both new and longstanding.
  • BIDMC’s research program is accredited by the Association for Accreditation of Human Research Protection Programs, Inc. (AAHRPP) and the Association for Assessment and Accreditation of Lab Animal Care International (AAALAC International).
  • Studies by BIDMC researchers are routinely published in the world’s leading scientific and medical journals including Nature, Science, Cell and The New England Journal of Medicine.